Al-Toubat M - Search Results

1

Protein kinase D1 mitigation against etoposide induced DNA damage in prostate cancer is associated with increased α-Catenin.

Shukla S, Osumi T, Al-Toubat M, Serrano S, Singh PK, Mietzsch M, McKenna R, Chardon-Robles J, Krishnan S, Balaji KC. Shukla S, et al. Among authors: al toubat m. Prostate. 2025 Feb;85(2):156-164. doi: 10.1002/pros.24812. Epub 2024 Oct 20. Prostate. 2025. PMID: 39428693

2

MRI-based radiomic features for identifying recurrent prostate cancer after proton radiation therapy.

Gumus KZ, Contreras SS, Al-Toubat M, Harmon I, Hernandez M, Ozdemir S, Kumar S, Yuruk N, Mete M, Balaji KC, Bandyk M, Gopireddy DR. Gumus KZ, et al. Among authors: al toubat m. J Appl Clin Med Phys. 2024 Feb 26;25(3):e14293. doi: 10.1002/acm2.14293. Online ahead of print. J Appl Clin Med Phys. 2024. PMID: 38409947 Free PMC article.

3

Metastatic prostate cancer is associated with distinct higher frequency of genetic mutations at diagnosis.

Al-Toubat M, Serrano S, Elshafei A, Koul K, Feibus AH, Balaji KC. Al-Toubat M, et al. Urol Oncol. 2023 Nov;41(11):455.e7-455.e15. doi: 10.1016/j.urolonc.2023.09.014. Epub 2023 Oct 13. Urol Oncol. 2023. PMID: 37838503

4

The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth.

Shukla S, Riveros C, Al-Toubat M, Chardon-Robles J, Osumi T, Serrano S, Kase AM, Petit JL, Meurice N, Gleba J, Copland JA 3rd, Chauhan J, Fletcher S, Balaji KC. Shukla S, et al. Among authors: al toubat m. Cancers (Basel). 2023 Jul 28;15(15):3851. doi: 10.3390/cancers15153851. Cancers (Basel). 2023. PMID: 37568667 Free PMC article.

5

Genetic mutations in smoking-associated prostate cancer.

Elshafei A, Al-Toubat M, Feibus AH, Koul K, Jazayeri SB, Lelani N, Henry V, Balaji KC. Elshafei A, et al. Among authors: al toubat m. Prostate. 2023 Sep;83(13):1229-1237. doi: 10.1002/pros.24554. Epub 2023 Jul 16. Prostate. 2023. PMID: 37455402

6

Urinary stone disease burden is increased in patients with cognitive impairment.

Elshafei A, Chalfant V, Al-Toubat M, Riveros C, Feibus A, Bazargani S, Jazayeri SB, Marino R, Balaji KC. Elshafei A, et al. Among authors: al toubat m. Am J Clin Exp Urol. 2023 Jun 15;11(3):249-257. eCollection 2023. Am J Clin Exp Urol. 2023. PMID: 37441445 Free PMC article.

7

Extramural venous invasion: a novel magnetic resonance imaging biomarker for adverse pathology in bladder cancer.

Bazargani S, Lall C, Gopireddy DR, Liu S, Way A, Al-Toubat M, Elshafei A, Feibus A, Jazayeri SB, Alam UM, Chalfant V, Kumar J, Marino R, Costa J, Ganapathi HP, Koochekpour S, Gautam S, Balaji KC, Bandyk MG. Bazargani S, et al. Among authors: al toubat m. Am J Clin Exp Urol. 2023 Apr 15;11(2):185-193. eCollection 2023. Am J Clin Exp Urol. 2023. PMID: 37168940 Free PMC article.

8

The impact of socioeconomic status on the survival of men with early-onset prostate cancer.

Riveros C, Al-Toubat M, Chalfant V, Elshafei A, Feibus A, Forero A, Balaji KC. Riveros C, et al. Among authors: al toubat m. Am J Clin Exp Urol. 2023 Apr 15;11(2):146-154. eCollection 2023. Am J Clin Exp Urol. 2023. PMID: 37168939 Free PMC article.

9

Magnetic resonance imaging radiomic features for recurrent prostate cancer following proton radiation therapy-A pilot study.

Bazargani S, Feibus AH, Elshafei A, Al-Toubat M, Gopireddy DR, Gautam S, Barwari S, Henderson R, Lall C, Balaji KC, Bandyk M. Bazargani S, et al. Among authors: al toubat m. Urol Oncol. 2023 Mar;41(3):145.e1-145.e5. doi: 10.1016/j.urolonc.2022.10.007. Epub 2022 Dec 8. Urol Oncol. 2023. PMID: 36496342

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters